Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,175 recruiting studies in this area right now.
By phase
- Not applicable2,709
- Phase 2362
- Phase 4321
- Phase 1291
- Phase 3285
- Phase 1/Phase 2142
- Phase 2/Phase 365
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University32
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California235
- Maryland147
- Alabama89
- New York77
- Florida74
- Texas61
- Massachusetts56
- Arizona47
- Pennsylvania45
- Illinois42
Recruiting studies4,175 total
- NCT06010433Recruiting
CERAMENT G treatment tracking study
This study tracks how well the CERAMENT G device works for people getting it as part of their treatment. It helps doctors gather real-world safety and effectiveness information.
San Diego, CaliforniaAges 18 years+ - NCT07698769Recruiting
Nirsevimab study for infants with RSV bronchiolitis
This trial looks at how well the drug nirsevimab works for babies hospitalized with RSV bronchiolitis. It also studies the body's immune response and the baby's environment. The goal is to see if nirsevimab can help infants recover from this serious lung infection.
CréteilAges birth–6 months - NCT05708508RecruitingPhase 3
Immune-guided vs universal medicine to prevent CMV after kidney transplant
This study compares two strategies to prevent a viral infection called CMV after kidney transplant. It tests whether an “immune-guided” approach (using your immune test results) can prevent CMV as well as or better than giving preventive antiviral medicine to everyone.
RouenAges 18–75 - NCT06711562Recruiting
Personalized Dosing for Bone and Joint Infection
This study aims to customize anti-infection medication doses for people with bone or joint infections. The goal is to make treatment more effective and reduce side effects.
JinanAges Any age - NCT06990126Enrolling by invitation
New tetracycline for drug-resistant bacterial infections
This trial tests a new tetracycline antibiotic (neotetracycline) for treating infections caused by drug-resistant Gram-negative bacteria. It aims to see how well the drug works and what side effects it may have.
Nanjing, JiangsuAges 18 years+ - NCT06656351RecruitingPhase 2
Study of tafenoquine for chronic babesiosis with fatigue
This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.
New York, New YorkAges 18 years+ - NCT06464770Recruiting
Improving infection prevention before shoulder surgery
This study compares different ways to clean the skin before shoulder surgery to prevent infection. It might help if you are going to have shoulder surgery and want safer, more effective infection prevention.
Seattle, WashingtonAges 18–89 - NCT07481175RecruitingPhase 1
Testing a drug to reduce hidden HIV early after treatment start
This trial tests whether adding venetoclax, a drug that helps infected cells die, at the start of HIV treatment can lower the amount of hidden virus that stays in the body. It may help reduce the HIV reservoir.
AarhusAges 18–70 - NCT07181486RecruitingPhase 1
Safety study of a vaginal gel for healthy women
This trial tests a gel placed in the vagina to see if it is safe. Healthy women with regular periods who have a steady partner may join.
San Francisco, CaliforniaAges 18–45 - NCT07525427RecruitingPhase 2
New Tuberculosis Drug Study for Drug-Sensitive TB
This study tests a new tuberculosis drug called TBD09 combined with other TB medicines in people with newly diagnosed, drug-sensitive TB. The goal is to see if this combination works well and is safe.
Durban, BluffAges 18–65 - NCT04672525RecruitingPhase 3
Rifabutin versus rifampicin for knee or hip staph implant infection
This Phase 3 trial compares two antibiotics—rifabutin and rifampicin—for treating staphylococcal (staph) infections around hip or knee joint implants when the implant is kept in place after cleaning (DAIR). It aims to see which drug works better to stop the infection from coming back.
AmiensAges 18 years+ - NCT07710664RecruitingPhase 1
New drug for persistent anal HPV16 infection
This trial tests a new drug (NWRD09) for people who have had HPV type 16 infection in the anal area for over a year. It aims to see if the drug can help clear the virus without causing serious side effects.
BeijingAges 18–60 - NCT07672067Recruiting
Talking about sexuality with your teen
This study tests a program to help parents talk with their teen sons about sexuality. It may help families feel more comfortable discussing important topics.
Philadelphia, PennsylvaniaAges 12–100 - NCT06485154RecruitingPhase 4
Finding the best HIV treatment after PrEP shot failure
This trial is for people who got exposed to HIV despite taking the long-acting PrEP shot (cabotegravir). It tests different pill-based HIV treatment plans to find the best option for them.
Johannesburg, GautengAges 15 years+ - NCT06474442RecruitingPhase 2
BD111 gene therapy for herpes simplex virus eye infection
This trial tests a new gene therapy called BD111 for people with a herpes simplex virus infection in the cornea (the clear front part of the eye). It aims to see if the treatment is safe and can help clear the virus, possibly improving vision.
Wenzhou, ZhejiangAges 18–70 - NCT06602622RecruitingPhase 4
Weight change study for people with HIV switching to DOR/3TC/TDF
This study tests whether switching your HIV medication to a combination called DOR/3TC/TDF can help with weight changes that started after taking another type of HIV drug (integrase inhibitor). It is for people who have gained weight unintentionally and want to see if a different medication helps manage it.
Mexico City, AzcapotzalcoAges 18–80 - NCT07655804RecruitingPhase 3
Calcitonin injection for shingles pain in older adults
This trial tests whether a medication called calcitonin (given as a shot under the skin) can help reduce pain in people with a recent shingles outbreak. It is for adults 50 and older who have moderate to severe pain from their rash.
Tanta, Gharbia GovernorateAges 50 years+ - NCT05584397Enrolling by invitation
Compare immune activity and HIV hidden reservoir on two treatments
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
Seattle, WashingtonAges 18–65 - NCT06637332RecruitingPhase 4
Comparing two drugs for MRSA bloodstream infections
This trial compares two antibiotics, vancomycin and daptomycin, to see which works better for treating MRSA bacteria in the blood. Patients are randomly assigned to one of the drugs and will be monitored closely for results and side effects.
Blacktown, New South WalesAges 18 years+ - NCT07516262Recruiting
How Stomach Acid Medication Affects H. Pylori Detection
This study looks at whether a common stomach acid medication (PPIs) affects the accuracy of a stool test for detecting H. pylori, a bacteria that can cause ulcers and stomach inflammation. Understanding this helps doctors know when the stool test works best.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06998264Recruiting
Immune response to flu in young children
This study looks at how children's immune systems fight the flu in the nose and throat. It aims to understand why some children get very sick and others don't, which could help create better treatments and vaccines.
GenevaAges 2–5 - NCT06479941Recruiting
Antibiotics in pregnancy and baby's gut health
This study looks at how antibiotics taken during pregnancy might affect the bacteria in your baby's gut. Researchers want to learn if this early exposure influences your baby's health.
BeijingAges 1 day–1 year - NCT07498075Recruiting
Digital messages to help Nigerian parents decide about HPV vaccine
This study tests digital messages (like texts or videos) to help parents in Nigeria decide about the HPV vaccine for their daughters. The vaccine protects against certain cancers, and the goal is to see what messages work best.
LagosAges 27 years+ - NCT06472271Recruiting
Personalized colistin dosing for premature newborns
This study aims to find the best dose of the antibiotic colistin for premature babies (born before 37 weeks) in the neonatal intensive care unit who have a serious infection that is resistant to other antibiotics. The goal is to treat the infection effectively while reducing the risk of kidney damage.
CairoAges birth–4 weeks
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,175 recruiting infectious disease studies from the U.S. registry right now, out of 7,037 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.